First Patient Enrolled In FDA-Approved Clinical Trial Of CBD-Based Drug For Treatment Of PTSD
The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. announced that the first patient has been enrolled in an FDA-approved clinical trial evaluating Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure delivery technology, for
